115 related articles for article (PubMed ID: 9339702)
1. Fluorodopa and raclopride PET analysis of patients with Machado-Joseph disease.
Shinotoh H; Thiessen B; Snow BJ; Hashimoto S; MacLeod P; Silveira I; Rouleau GA; Schulzer M; Calne DB
Neurology; 1997 Oct; 49(4):1133-6. PubMed ID: 9339702
[TBL] [Abstract][Full Text] [Related]
2. Decreased dopamine transporter binding in Machado-Joseph disease.
Yen TC; Lu CS; Tzen KY; Wey SP; Chou YH; Weng YH; Kao PF; Ting G
J Nucl Med; 2000 Jun; 41(6):994-8. PubMed ID: 10855623
[TBL] [Abstract][Full Text] [Related]
3. Levodopa-induced changes in synaptic dopamine in patients with Parkinson's disease as measured by [11C]raclopride displacement and PET.
Tedroff J; Pedersen M; Aquilonius SM; Hartvig P; Jacobsson G; Långström B
Neurology; 1996 May; 46(5):1430-6. PubMed ID: 8628494
[TBL] [Abstract][Full Text] [Related]
4. Presynaptic and postsynaptic striatal dopaminergic function in patients with manganese intoxication: a positron emission tomography study.
Shinotoh H; Snow BJ; Chu NS; Huang CC; Lu CS; Lee C; Takahashi H; Calne DB
Neurology; 1997 Apr; 48(4):1053-6. PubMed ID: 9109899
[TBL] [Abstract][Full Text] [Related]
5. Comparison of striatal 18F-dopa uptake in adult-onset dystonia-parkinsonism, Parkinson's disease, and dopa-responsive dystonia.
Turjanski N; Bhatia K; Burn DJ; Sawle GV; Marsden CD; Brooks DJ
Neurology; 1993 Aug; 43(8):1563-8. PubMed ID: 8351012
[TBL] [Abstract][Full Text] [Related]
6. Complementary PET studies of striatal neuronal function in the differential diagnosis between multiple system atrophy and Parkinson's disease.
Antonini A; Leenders KL; Vontobel P; Maguire RP; Missimer J; Psylla M; Günther I
Brain; 1997 Dec; 120 ( Pt 12)():2187-95. PubMed ID: 9448574
[TBL] [Abstract][Full Text] [Related]
7. Asymmetrical pre-synaptic and post-synpatic changes in the striatal dopamine projection in dopa naïve parkinsonism. Diagnostic implications of the D2 receptor status.
Sawle GV; Playford ED; Brooks DJ; Quinn N; Frackowiak RS
Brain; 1993 Aug; 116 ( Pt 4)():853-67. PubMed ID: 8353712
[TBL] [Abstract][Full Text] [Related]
8. Dopamine transporter concentration is reduced in asymptomatic Machado-Joseph disease gene carriers.
Yen TC; Tzen KY; Chen MC; Chou YH; Chen RS; Chen CJ; Wey SP; Ting G; Lu CS
J Nucl Med; 2002 Feb; 43(2):153-9. PubMed ID: 11850478
[TBL] [Abstract][Full Text] [Related]
9. Cognitive and olfactory deficits in Machado-Joseph disease: a dopamine transporter study.
Braga-Neto P; Felicio AC; Hoexter MQ; Pedroso JL; Dutra LA; Alessi H; Minett T; Santos-Galduroz RF; da Rocha AJ; Garcia LA; Bertolucci PH; Bressan RA; Barsottini OG
Parkinsonism Relat Disord; 2012 Aug; 18(7):854-8. PubMed ID: 22575233
[TBL] [Abstract][Full Text] [Related]
10. Striatal D2 receptor status in patients with Parkinson's disease, striatonigral degeneration, and progressive supranuclear palsy, measured with 11C-raclopride and positron emission tomography.
Brooks DJ; Ibanez V; Sawle GV; Playford ED; Quinn N; Mathias CJ; Lees AJ; Marsden CD; Bannister R; Frackowiak RS
Ann Neurol; 1992 Feb; 31(2):184-92. PubMed ID: 1575457
[TBL] [Abstract][Full Text] [Related]
11. D2 receptor binding in dopa-responsive dystonia.
Künig G; Leenders KL; Antonini A; Vontobel P; Weindl A; Meinck HM
Ann Neurol; 1998 Nov; 44(5):758-62. PubMed ID: 9818931
[TBL] [Abstract][Full Text] [Related]
12. Positron emission tomography (PET) in Machado-Joseph disease.
Taniwaki T; Sakai T; Kobayashi T; Kuwabara Y; Otsuka M; Ichiya Y; Masuda K; Goto I
J Neurol Sci; 1997 Jan; 145(1):63-7. PubMed ID: 9073030
[TBL] [Abstract][Full Text] [Related]
13. Striatal dopaminergic function in restless legs syndrome: 18F-dopa and 11C-raclopride PET studies.
Turjanski N; Lees AJ; Brooks DJ
Neurology; 1999 Mar; 52(5):932-7. PubMed ID: 10102408
[TBL] [Abstract][Full Text] [Related]
14. [11C]raclopride and positron emission tomography in previously untreated patients with Parkinson's disease: Influence of L-dopa and lisuride therapy on striatal dopamine D2-receptors.
Antonini A; Schwarz J; Oertel WH; Beer HF; Madeja UD; Leenders KL
Neurology; 1994 Jul; 44(7):1325-9. PubMed ID: 8035939
[TBL] [Abstract][Full Text] [Related]
15. The relationship between locomotor disability, autonomic dysfunction, and the integrity of the striatal dopaminergic system in patients with multiple system atrophy, pure autonomic failure, and Parkinson's disease, studied with PET.
Brooks DJ; Salmon EP; Mathias CJ; Quinn N; Leenders KL; Bannister R; Marsden CD; Frackowiak RS
Brain; 1990 Oct; 113 ( Pt 5)():1539-52. PubMed ID: 2123119
[TBL] [Abstract][Full Text] [Related]
16. PET studies of the presynaptic and postsynaptic dopaminergic system in Tourette's syndrome.
Turjanski N; Sawle GV; Playford ED; Weeks R; Lammerstma AA; Lees AJ; Brooks DJ
J Neurol Neurosurg Psychiatry; 1994 Jun; 57(6):688-92. PubMed ID: 7911827
[TBL] [Abstract][Full Text] [Related]
17. Long-term changes of striatal dopamine D2 receptors in patients with Parkinson's disease: a study with positron emission tomography and [11C]raclopride.
Antonini A; Schwarz J; Oertel WH; Pogarell O; Leenders KL
Mov Disord; 1997 Jan; 12(1):33-8. PubMed ID: 8990051
[TBL] [Abstract][Full Text] [Related]
18. Measuring the rate of progression and estimating the preclinical period of Parkinson's disease with [18F]dopa PET.
Morrish PK; Rakshi JS; Bailey DL; Sawle GV; Brooks DJ
J Neurol Neurosurg Psychiatry; 1998 Mar; 64(3):314-9. PubMed ID: 9527140
[TBL] [Abstract][Full Text] [Related]
19. Dopamine D2 receptors in normal human brain: effect of age measured by positron emission tomography (PET) and [11C]-raclopride.
Antonini A; Leenders KL
Ann N Y Acad Sci; 1993 Sep; 695():81-5. PubMed ID: 8239318
[TBL] [Abstract][Full Text] [Related]
20. Differences in the reduced 18F-Dopa uptakes of the caudate and the putamen in Parkinson's disease: correlations with the three main symptoms.
Otsuka M; Ichiya Y; Kuwabara Y; Hosokawa S; Sasaki M; Yoshida T; Fukumura T; Masuda K; Kato M
J Neurol Sci; 1996 Mar; 136(1-2):169-73. PubMed ID: 8815166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
